At 15.2 crore, record number of Indian flyers in 2023
Monday, 15 January 2024 Domestic air travel in India surpassed pre-Covid levels, with 15.2 crore domestic air travelers in 2023, the highest ever recorded. IndiGo had a market share of 60.5%, while the combined market share of Tata group airlines was 26%. December had the highest monthly air traffic at 13.8 million, and Akasa Air had the highest passenger load factor at 93.9%. DGCA data shows over 3.6 lakh domestic passengers faced flight delays last month and airlines spent over Rs 5.4 crore on their "facilitation."
A new intranasal vaccine developed by researchers at the Wuhan lab has recently been unveiled, promising a novel approach to combating infectious diseases. However, this breakthrough has also sparked significant controversy and concern. While the vaccineβs potential to offer a more accessible and efficient method of vaccination is hailed as a major advancement, its origins and the circumstances surrounding its development are raising alarms about a possible new health crisis. Critics worry that the technology used in this vaccine could inadvertently lead to another pandemic-like scenario if not carefully monitored. As the world cautiously watches, the vaccine's rollout is stirring a heated debate about safety, preparedness, and the ethical implications of such advanced biological research.
#IntranasalVaccine #WuhanLab #CovidCrisis #HealthFears #VaccineDebate #PandemicRisk #BioResearch #VaccineDevelopment #PublicHealth #InfectiousDiseases #SafetyConcerns #GlobalHealth #VaccineInnovation #EthicalIssues #HealthSecurity
~HT.97~PR.152~
Monday, 15 January 2024
![Cure or Threat? Wuhan Lab's New Intranasal Vaccine Sparks Fears of Another Covid-like Crisis [Video]](https://video.newsserve.net/300/v/20240912/1387343466-Cure-or-Threat-Wuhan-Lab-New-Intranasal.jpg)
